Clinical Trials
13
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5
- Conditions
- Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)
- Interventions
- Drug: OctenidinedihydrochloridOther: Placebo
- First Posted Date
- 2017-12-19
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- Schülke & Mayr GmbH
- Target Recruit Count
- 114
- Registration Number
- NCT03378401
- Locations
- 🇦🇹
Universitätszahnklinik Wien, Fachbereich Zahnerhaltung und Parodontologie, Wien, Austria
🇩🇪Poliklinik für Zahnerhaltung und Parodontologie des Universitätsklinikums Würzburg, Würzburg, Bavaria, Germany
🇩🇪Poliklinik für Zahnerhaltung und Parodontologie der Universitätsklinik Köln, Köln, North Rhine-Westphalia, Germany
Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5
- Conditions
- Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)
- Interventions
- Drug: OctenidinedihydrochloridOther: Placebo
- First Posted Date
- 2017-10-26
- Last Posted Date
- 2019-01-22
- Lead Sponsor
- Schülke & Mayr GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT03322124
- Locations
- 🇩🇪
Poliklinik für Parodontologie der Johann Wolfgang Goethe Universität Frankfurt am Main, Frankfurt am Main, Hesse, Germany
🇩🇪Poliklinik für Parodontologie der Med. Fakultät C. G. Carus der TU Dresden, Dresden, Saxony, Germany
🇩🇪Poliklinik für Zahnerhaltung und Parodontologie am Universitätsklinikum Leipzig, Leipzig, Saxony, Germany
Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo
- First Posted Date
- 2014-05-14
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Schülke & Mayr GmbH
- Target Recruit Count
- 90
- Registration Number
- NCT02138552
- Locations
- 🇩🇪
Poliklinik für Parodontologie Med. Fakultät C. G. Carus der TU Dresden, Dresden, Germany
🇩🇪Abteilung für Parodontologie in der Poliklinik für Zahnerhaltung und Parodontologie der Universität Würzburg, Würzburg, Germany
Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds
- Conditions
- Ulcus Cruris
- Interventions
- Drug: PlaceboDrug: octenisept®
- First Posted Date
- 2011-09-15
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- Schülke & Mayr GmbH
- Target Recruit Count
- 9
- Registration Number
- NCT01434914
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany